InvestorsHub Logo
Followers 59
Posts 2197
Boards Moderated 4
Alias Born 04/28/2019

Re: None

Sunday, 08/18/2019 7:39:09 PM

Sunday, August 18, 2019 7:39:09 PM

Post# of 20617
INNV - INNOVUS PHARMA has huge upside potential, bullish technically.

EARNINGS CALL TRANSCRIPT FROM BASSAM DAMAJ ( CEO )(source seeking alpha)
Our business and financial performance keep improving as we continued to control our top line revenue, increased our net margin and decrease our cash burn from operations and our net loss as you have seen from our second quarter filing this afternoon with the SEC. Specifically, we increased our revenue to approximately $6.8 million which is an increase of $1.2 million or 27% compared to prior quarter.

Year-to-date revenue approximately $12.2 million in 2019, compared to $11.9 million in 2018. We increased focused on our highly profitable Canadian market representing 26% for the three months ended June 30, 2019, compared with only 13% for the previous quarter.

Quarterly product subscription and outbound concierge net revenue of $1.1 million compared to $0.7 million in the prior year, which makes it a 57.1% increase and this resulted in the following company financial improvement.


Official InvestorsHub (IHUB) Profile for TopMarketGainers.com. Since 2009,
we are the #1 Source For #FREE Winning #NASDAQ & #NYSE-Listed Alerts!

IHUB Board: https://investorshub.advfn.com/Chart-Analysis-TopMarketGainerscom-36847/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.